Viking Therapeutics (VKTX) Return on Assets (2016 - 2025)
Historic Return on Assets for Viking Therapeutics (VKTX) over the last 11 years, with Q4 2025 value amounting to 0.49%.
- Viking Therapeutics' Return on Assets fell 3800.0% to 0.49% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.49%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.44% for FY2025, which is 2700.0% down from last year.
- Per Viking Therapeutics' latest filing, its Return on Assets stood at 0.49% for Q4 2025, which was down 3800.0% from 0.3% recorded in Q3 2025.
- Viking Therapeutics' 5-year Return on Assets high stood at 0.1% for Q2 2024, and its period low was 0.49% during Q4 2025.
- In the last 5 years, Viking Therapeutics' Return on Assets had a median value of 0.23% in 2021 and averaged 0.25%.
- Per our database at Business Quant, Viking Therapeutics' Return on Assets skyrocketed by 3100bps in 2024 and then tumbled by -3800bps in 2025.
- Quarter analysis of 5 years shows Viking Therapeutics' Return on Assets stood at 0.25% in 2021, then crashed by -62bps to 0.41% in 2022, then skyrocketed by 44bps to 0.23% in 2023, then surged by 48bps to 0.12% in 2024, then plummeted by -315bps to 0.49% in 2025.
- Its Return on Assets stands at 0.49% for Q4 2025, versus 0.3% for Q3 2025 and 0.2% for Q2 2025.